An article co-authored by Dennis Anderson, Joellen Ledford, Mary White, Dr. Neil Quigley and their colleagues is published in the October 2011 issue of the American Journal of Clinical Pathology. Read the rest of this entry »
Analytical performance data from a recent study support the use of the Cervista® HPV 16/18 genotyping test for detection and differentiation of HPV 16 and 18 in ThinPrep cervical cytology specimens. Read the rest of this entry »
Drs. Neil Quigley and Nicholas Potter co-authored a recent article comparing two assays’ detection rate of the human papillomavirus (HPV) in women 30 years of age and older. Read the rest of this entry »
Ajenda Healthcare Marketing, a division of Molecular Pathology Laboratory Network, Inc. (MPLN), submitted the winning logo to the International Clinical Cytometry Society (ICCS), which serves the international clinical flow cytometry community by facilitating education and advancement within the industry. Read the rest of this entry »
Indigenous Guyanese women have a high rate of cervical cancer and high-grade dysplasia, with an apparent predominance of HPV 16 and 18 in invasive cancer and over representation of HPV 31 in high-grade dysplasia, according to a recent study. Read the rest of this entry »
Ajenda Healthcare Marketing, a division of Molecular Pathology Laboratory Network, Inc. (MPLN), recently launched its new website at www.ajendamarketing.com.
Read the rest of this entry »
Dr. Neil Quigley, vice president of Geneuity® Clinical Research Services, recently gained licensure with the State of Tennessee as a Medical Laboratory Director in Molecular Diagnostics. Read the rest of this entry »
Molecular Pathology Laboratory Network, Inc. (MPLN) recently announced that the United States Patent and Trademark Office (USPTO) granted trademark registration for the name of one of its divisions, Geneuity® Clinical Research Services, effective on September 15, 2009. Read the rest of this entry »
Geneuity™ Clinical Research Services announces the recent validation and use in clinical trials of two human biomarker assays that play a key role in the early detection of kidney damage. Read the rest of this entry »
Ranee Taylor, PhD, director of business development for Geneuity Clinical Research Services, was recently named to the editorial advisory board for “Pharmaceutical Outsourcing.” Read the rest of this entry »